Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

Mepron (Atovaquone) Suspension
Company:  Glaxo Wellcome, Inc.
Application No.:  20-500/S-005
Approval Date: 1/5/1999


Date created: March 30, 2001; last update: July 5, 2005

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.